| Primary |
| Hypertension |
36.7% |
| Metastatic Pain |
12.2% |
| Atrial Fibrillation |
10.2% |
| Essential Hypertension |
10.2% |
| Nerve Block |
6.1% |
| Alcohol Detoxification |
4.1% |
| Lung Infection |
4.1% |
| Neuralgia |
4.1% |
| Fluid Retention |
2.0% |
| Hypertensive Crisis |
2.0% |
| Magnesium Deficiency |
2.0% |
| Myocardial Ischaemia |
2.0% |
| Pain In Extremity |
2.0% |
| Prophylaxis |
2.0% |
|
| Suicide Attempt |
12.9% |
| Hypotension |
9.7% |
| Bradyarrhythmia |
6.5% |
| Hypertensive Crisis |
6.5% |
| Medication Error |
6.5% |
| Paraparesis |
6.5% |
| Sedation |
6.5% |
| Ventricular Tachycardia |
6.5% |
| Coma |
3.2% |
| Confusional State |
3.2% |
| Leukopenia |
3.2% |
| Renal Failure Acute |
3.2% |
| Sciatic Nerve Neuropathy |
3.2% |
| Syncope |
3.2% |
| Therapeutic Response Decreased |
3.2% |
| Tongue Biting |
3.2% |
| Tongue Oedema |
3.2% |
| Transient Ischaemic Attack |
3.2% |
| Unresponsive To Stimuli |
3.2% |
| White Blood Cell Count Increased |
3.2% |
|
| Secondary |
| Supplementation Therapy |
13.6% |
| Hypertension |
13.2% |
| Product Used For Unknown Indication |
11.7% |
| Psoas Abscess |
9.6% |
| Pain |
9.1% |
| Pancreatitis |
6.0% |
| Thrombosis Prophylaxis |
4.4% |
| Depression |
4.2% |
| Hyperglycaemia |
4.0% |
| Restlessness |
3.1% |
| Fluid Replacement |
2.7% |
| Sedation |
2.7% |
| Polyuria |
2.4% |
| Pyrexia |
2.2% |
| Constipation |
2.0% |
| Prophylaxis |
2.0% |
| Alcohol Withdrawal Syndrome |
1.8% |
| Nausea |
1.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.8% |
| Secretion Discharge |
1.8% |
|
| Stevens-johnson Syndrome |
26.1% |
| Joint Swelling |
13.0% |
| Coma |
8.7% |
| Toxic Epidermal Necrolysis |
8.7% |
| Syncope |
6.5% |
| Haemoglobin Decreased |
4.3% |
| Stomatitis |
4.3% |
| Bacterial Infection |
2.2% |
| Completed Suicide |
2.2% |
| Exposure During Pregnancy |
2.2% |
| Hypoxia |
2.2% |
| Renal Failure Acute |
2.2% |
| Respiratory Tract Infection |
2.2% |
| Sciatic Nerve Neuropathy |
2.2% |
| Self Injurious Behaviour |
2.2% |
| Sinus Bradycardia |
2.2% |
| Unintended Pregnancy |
2.2% |
| Urticaria |
2.2% |
| Vomiting |
2.2% |
| White Blood Cell Count Increased |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.3% |
| Hypertension |
22.2% |
| Drug Use For Unknown Indication |
19.0% |
| Diabetes Mellitus |
4.5% |
| Atrial Fibrillation |
2.8% |
| Systemic Sclerosis |
2.8% |
| Transplant |
2.3% |
| Acth Decreased |
1.7% |
| Epilepsy |
1.7% |
| Thrombosis Prophylaxis |
1.7% |
| Depression |
1.4% |
| Type 2 Diabetes Mellitus |
1.4% |
| Breast Cancer |
1.1% |
| Constipation |
1.1% |
| Diarrhoea |
1.1% |
| Erectile Dysfunction |
1.1% |
| Essential Hypertension |
1.1% |
| Follicle-stimulating Hormone Deficiency |
1.1% |
| Headache |
1.1% |
| Hypercholesterolaemia |
1.1% |
|
| Renal Failure Acute |
8.9% |
| Blood Pressure Increased |
7.1% |
| Megacolon |
7.1% |
| Oliguria |
7.1% |
| Pericardial Effusion |
7.1% |
| Ventricular Tachycardia |
7.1% |
| Shock |
5.4% |
| Vomiting |
5.4% |
| Weight Decreased |
5.4% |
| Anaemia |
3.6% |
| Cerebrovascular Accident |
3.6% |
| Encephalopathy |
3.6% |
| Haemoglobin Decreased |
3.6% |
| Haemorrhage |
3.6% |
| Hyperkalaemia |
3.6% |
| Hypertensive Crisis |
3.6% |
| Myocardial Infarction |
3.6% |
| Photosensitivity Reaction |
3.6% |
| Pseudoporphyria |
3.6% |
| Pulmonary Oedema |
3.6% |
|
| Interacting |
| Hypovitaminosis |
43.2% |
| Depressive Symptom |
21.6% |
| Hypertension |
21.6% |
| General Anaesthesia |
13.5% |
|
| Rash Pruritic |
44.4% |
| Tinnitus |
44.4% |
| Drug Interaction |
11.1% |
|
